Home
PFE
PFE News

Latest Pfizer Inc. (PFE) News on September 1, 2025

Large-cap biotech is a sector to watch for investors: Analysts

Yahoo Finance

16 hours ago

Large-cap biotech is a sector to watch for investors: Analysts

3 No-Brainer Stocks to Buy Right Now

Motley Fool

18 hours ago

3 No-Brainer Stocks to Buy Right Now

Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine

Insider Monkey

a day ago

Pfizer (PFE) Announces FDA Approval of sBLA for Pfizer-BioNTech COVID-19 Vaccine

4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizer

Motley Fool

2 days ago

4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizer

Better High-Yielding Dividend Stock: Realty Income vs. Pfizer

Motley Fool

2 days ago

Better High-Yielding Dividend Stock: Realty Income vs. Pfizer

Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day

Zacks

3 days ago

Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day

If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now

Zacks

3 days ago

If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now

Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally

Insider Monkey

3 days ago

Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally

Inside the Trump Administration’s Vaccine Politics

The Wall Street Journal

3 days ago

Inside the Trump Administration’s Vaccine Politics

FDA Approves Updated COVID-19 Vaccines but With Restrictions

Zacks

4 days ago

FDA Approves Updated COVID-19 Vaccines but With Restrictions

MRK, Daiichi Begin Phase III Breast Cancer Study With ADC Candidate

Zacks

4 days ago

MRK, Daiichi Begin Phase III Breast Cancer Study With ADC Candidate

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?

Zacks

4 days ago

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?

Can Pfizer's Cost Cuts and New Drugs Offset Upcoming Headwinds?

Zacks

4 days ago

Can Pfizer's Cost Cuts and New Drugs Offset Upcoming Headwinds?

FDA approves mRNA vaccines for new Covid-19 season amid political tension

Pharmaceutical Technology

4 days ago

FDA approves mRNA vaccines for new Covid-19 season amid political tension

Does Enanta’s EU Lawsuit Over Paxlovid Shift the Bull Case for Pfizer (PFE)?

Simply Wall St.

4 days ago

Does Enanta’s EU Lawsuit Over Paxlovid Shift the Bull Case for Pfizer (PFE)?

Morningstar Research

4 days ago

Analyst Report: Pfizer Inc.

Morgan Stanley Lifts Pfizer (PFE) Price Target, Keeps Equalweight Rating

Insider Monkey

4 days ago

Morgan Stanley Lifts Pfizer (PFE) Price Target, Keeps Equalweight Rating

RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.

Investor's Business Daily

4 days ago

RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.

MT Newswires

4 days ago

Sector Update: Health Care Stocks Mixed Late Afternoon

MT Newswires

4 days ago

Sector Update: Health Care Stocks Advance Wednesday Afternoon

FDA Approves Pfizer Covid Vaccine but Adds Restrictions on Its Use

Barrons.com

4 days ago

FDA Approves Pfizer Covid Vaccine but Adds Restrictions on Its Use

Business Wire

5 days ago

ADVANCE 2025 Returns September 17 in New York City Featuring Global CMOs, Big Tech Leaders, and Wyclef Jean

LLY vs. PFE: Which Pharma Giant Is the Better Pick for Investors?

Zacks

5 days ago

LLY vs. PFE: Which Pharma Giant Is the Better Pick for Investors?

HER2+ Breast Cancer Clinical Trials Analysis Report 2025 - Enhance Your Understanding of Trial Counts and Enrollment Trends Across G7 & E7 Countries

GlobeNewswire

5 days ago

HER2+ Breast Cancer Clinical Trials Analysis Report 2025 - Enhance Your Understanding of Trial Counts and Enrollment Trends Across G7 & E7 Countries

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic

GlobeNewswire

5 days ago

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma

GlobeNewswire

5 days ago

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma

Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'

Benzinga

5 days ago

Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'

GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU

Zacks

6 days ago

GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU

Is There Now an Opportunity in Pfizer After FDA Covid Vaccine Review for Children?

Simply Wall St.

6 days ago

Is There Now an Opportunity in Pfizer After FDA Covid Vaccine Review for Children?

[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

7 days ago

[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Stocks slip on Wall Street after last week's rally

Associated Press Finance

7 days ago

Stocks slip on Wall Street after last week's rally

2 Reasons to Watch ZTS and 1 to Stay Cautious

StockStory

7 days ago

2 Reasons to Watch ZTS and 1 to Stay Cautious

3 Unstoppable Dividend Stocks to Buy Right Now

Motley Fool

9 days ago

3 Unstoppable Dividend Stocks to Buy Right Now

Arvinas, Inc. (NASDAQ:ARVN) Stake Jumps 194% at XTX Topco

Insider Monkey

9 days ago

Arvinas, Inc. (NASDAQ:ARVN) Stake Jumps 194% at XTX Topco

Top Analyst Reports for NVIDIA, Cisco & Linde

Zacks

9 days ago

Top Analyst Reports for NVIDIA, Cisco & Linde

AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth

Zacks

10 days ago

AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

Zacks

10 days ago

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth

Zacks

10 days ago

ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth

Investors Crave Long-Term Debt, But Firms Don’t Want to Sell

Bloomberg

10 days ago

Investors Crave Long-Term Debt, But Firms Don’t Want to Sell

My 5 Favorite Stocks to Buy Right Now

Motley Fool

10 days ago

My 5 Favorite Stocks to Buy Right Now

Enanta Files Patent Lawsuit Against Pfizer (PFE) Over COVID-19 Drug Paxlovid

Simply Wall St.

10 days ago

Enanta Files Patent Lawsuit Against Pfizer (PFE) Over COVID-19 Drug Paxlovid

Latest Fed cut signals, pharma relief rally, Apple TV+ price hike

Yahoo Finance Video

10 days ago

Latest Fed cut signals, pharma relief rally, Apple TV+ price hike

Padcev-Keytruda combo approved for NHS use in mUC

Pharmaceutical Technology

10 days ago

Padcev-Keytruda combo approved for NHS use in mUC

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

11 days ago

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

US-EU trade deal impacts on pharma industry more 'manageable' than expected

Yahoo Finance

11 days ago

US-EU trade deal impacts on pharma industry more 'manageable' than expected

Low Volatility Calls For This Breakout Trade On Pfizer Stock

Investor's Business Daily

11 days ago

Low Volatility Calls For This Breakout Trade On Pfizer Stock

Has Pfizer Inc.'s (NYSE:PFE) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Simply Wall St.

11 days ago

Has Pfizer Inc.'s (NYSE:PFE) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Leaders Come Together to Advance the Industry at Veeva Summit

PR Newswire

11 days ago

Leaders Come Together to Advance the Industry at Veeva Summit

How Much Would It Take To Earn $100 A Month From Pfizer Stock

Benzinga

11 days ago

How Much Would It Take To Earn $100 A Month From Pfizer Stock

Covid-19 Vaccine Guidelines Are Changing. What We Know About Who Can Get a Shot.

Barrons.com

11 days ago

Covid-19 Vaccine Guidelines Are Changing. What We Know About Who Can Get a Shot.

MT Newswires

11 days ago

Veeva Systems Q2 Results Likely In-Line to Better, Maintain H2 Outlook, Truist Says

Pfizer battles another Paxlovid lawsuit from Enanta

Pharmaceutical Technology

11 days ago

Pfizer battles another Paxlovid lawsuit from Enanta

MT Newswires

12 days ago

Enanta Pharmaceuticals Sues Pfizer Over COVID-19 Drug Patent in EU

Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union

Business Wire

12 days ago

Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union

My Top Dividend-Paying, Deep-Value Stock to Buy in August

Motley Fool

12 days ago

My Top Dividend-Paying, Deep-Value Stock to Buy in August

2 S&P 500 Stocks to Own for Decades and 1 We Ignore

StockStory

12 days ago

2 S&P 500 Stocks to Own for Decades and 1 We Ignore

3 Defensive Stocks That Can Weather Any Recession

Barchart

12 days ago

3 Defensive Stocks That Can Weather Any Recession

MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer

Zacks

13 days ago

MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer

Pfizer Oncology Drugs Drive Sales in Q2: Will the Trend Continue?

Zacks

13 days ago

Pfizer Oncology Drugs Drive Sales in Q2: Will the Trend Continue?

CNW Group

13 days ago

Pfizer Canada and HPIC Mark 30 Years of Humanitarian Partnership Delivering Global Health Impact

Argus Research

13 days ago

Analyst Report: Pfizer Inc.

Argus Research

13 days ago

Market Digest: BA, PFE, BRK/B, WBD, APO

Is Pfizer's 6.8%-Yielding Dividend Too Good to Be True?

Motley Fool

13 days ago

Is Pfizer's 6.8%-Yielding Dividend Too Good to Be True?

MT Newswires

13 days ago

Pfizer, BioNTech Updated COVID-19 Vaccine Approved by Health Canada

Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine

CNW Group

13 days ago

Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine

MT Newswires

14 days ago

Traws Pharma Gets Approval for Phase 2 COVID Studies With Ratutrelvir; Shares up Pre-Bell

MT Newswires

14 days ago

Rothschild & Co Redburn Adjusts Price Target on Pfizer to $25 From $27, Maintains Neutral Rating

Pfizer’s sickle cell disease candidate fails Phase III trial

Clinical Trials Arena

14 days ago

Pfizer’s sickle cell disease candidate fails Phase III trial

These 3 Dividend Stocks Have Yields Above 5%, Plus They Raise Their Payouts Every Year

Motley Fool

14 days ago

These 3 Dividend Stocks Have Yields Above 5%, Plus They Raise Their Payouts Every Year

Arvinas, Pfizer’s Vepdegestrant NDA Accepted by FDA for Breast Cancer Treatment

Insider Monkey

14 days ago

Arvinas, Pfizer’s Vepdegestrant NDA Accepted by FDA for Breast Cancer Treatment

Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial

Insider Monkey

15 days ago

Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial

Citi Raises PT on Pfizer Inc. (PFE) to $26; Maintains ‘Neutral’ Rating

Insider Monkey

15 days ago

Citi Raises PT on Pfizer Inc. (PFE) to $26; Maintains ‘Neutral’ Rating

2 Top Dividend Stocks to Buy on the Dip

Motley Fool

16 days ago

2 Top Dividend Stocks to Buy on the Dip

Pfizer Inc. (PFE) Comes Up With A Good Thing But No One Cares, Laments Jim Cramer

Insider Monkey

16 days ago

Pfizer Inc. (PFE) Comes Up With A Good Thing But No One Cares, Laments Jim Cramer

Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness

Insider Monkey

16 days ago

Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness

MT Newswires

17 days ago

Pfizer Says Inclacumab Fails to Meet Primary Endpoint in Phase 3 Trial for Sickle Cell Disease

AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs

Zacks

17 days ago

AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs

Big Pharma Has a New Vision for Selling Drugs. It’s Going to the Mattresses.

Barrons.com

17 days ago

Big Pharma Has a New Vision for Selling Drugs. It’s Going to the Mattresses.

Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial

BioPharma Dive

17 days ago

Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial

After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again?

Motley Fool

17 days ago

After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again?

Merck KGaA ventures into new territory in the US

Pharma Voice

17 days ago

Merck KGaA ventures into new territory in the US

If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?

Benzinga

18 days ago

If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?

Pfizer (PFE) Reports Promising Phase 3 Results For Bladder Cancer Treatment Combination

Simply Wall St.

18 days ago

Pfizer (PFE) Reports Promising Phase 3 Results For Bladder Cancer Treatment Combination

PFE New & Acquired Drugs Back 1H Top-Line Growth: Will the Trend Last?

Zacks

18 days ago

PFE New & Acquired Drugs Back 1H Top-Line Growth: Will the Trend Last?

Should You Now Consider Selling Your Pfizer (PFE) Shares Before its Too Late?

Insider Monkey

19 days ago

Should You Now Consider Selling Your Pfizer (PFE) Shares Before its Too Late?

Saudi Arabia Osteoporosis Drugs Market Analysis Report 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann La Roche, GlaxoSmithKline, Merck, Novartis, Pfizer, Teva Pharmaceutical, UCB

GlobeNewswire

19 days ago

Saudi Arabia Osteoporosis Drugs Market Analysis Report 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann La Roche, GlaxoSmithKline, Merck, Novartis, Pfizer, Teva Pharmaceutical, UCB

Will Zanzalintinib Ease Out EXEL's Reliance on Cabometyx for Growth?

Zacks

19 days ago

Will Zanzalintinib Ease Out EXEL's Reliance on Cabometyx for Growth?

3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer

Motley Fool

19 days ago

3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer

PFE Q2 Deep Dive: Margin Expansion and R&D Pipeline Fuel Outlook Amid Policy Uncertainty

StockStory

19 days ago

PFE Q2 Deep Dive: Margin Expansion and R&D Pipeline Fuel Outlook Amid Policy Uncertainty

The Top 5 Analyst Questions From Pfizer’s Q2 Earnings Call

StockStory

19 days ago

The Top 5 Analyst Questions From Pfizer’s Q2 Earnings Call

AbbVie to invest $195 million in North Chicago facility that will produce active pharmaceutical ingredients

Chicago Tribune

19 days ago

AbbVie to invest $195 million in North Chicago facility that will produce active pharmaceutical ingredients

Industry Leader in Lyophilization, Dr. Serguei Tchessalov, Partners with BioTechnique® to Enhance Customer Capabilities

Business Wire

19 days ago

Industry Leader in Lyophilization, Dr. Serguei Tchessalov, Partners with BioTechnique® to Enhance Customer Capabilities

MT Newswires

19 days ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

Pfizer (PFE) Reports Positive Phase 3 Results In Bladder Cancer Treatment Study

Simply Wall St.

19 days ago

Pfizer (PFE) Reports Positive Phase 3 Results In Bladder Cancer Treatment Study

MT Newswires

20 days ago

Market Chatter: Pfizer's COVID Vaccine Approval May Be Revoked by US FDA for Children Under 5 Years

Statutory Profit Doesn't Reflect How Good Pfizer's (NYSE:PFE) Earnings Are

Simply Wall St.

20 days ago

Statutory Profit Doesn't Reflect How Good Pfizer's (NYSE:PFE) Earnings Are

Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda

GlobeNewswire

20 days ago

Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda

MT Newswires

20 days ago

Market Chatter: Eli Lilly, Pfizer Among Drugmakers Eyeing a Spot in Chinese Commercial Health Insurance Catalog

MT Newswires

20 days ago

Pfizer, Astellas Say Padcev-Keytruda Combo Therapy Shows Improved Survival in Bladder Cancer Patients

PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery

Business Wire

20 days ago

PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery

Share on Social Networks: